Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Edelsten, C AU - Reddy, MA AU - Stanford, MR AU - Graham, EM TI - Visual loss associated with pediatric uveitis in English primary and referral centers J2 - Am J Ophthalmol PY - 2003 VL - 135 SP - 676 EP - 680 UR - https://doi.org/10.1016/S0002-9394(02)02148-7 ER - TY - JOUR LB - 2. AU - Smith, JA AU - Mackensen, F AU - Sen, HN AU - Leigh, JF AU - Watkins, AS AU - Pyatetsky, D TI - Epidemiology and course of disease in childhood uveitis J2 - Ophthalmology PY - 2009 VL - 116 SP - 1544 EP - 51e1 UR - https://doi.org/10.1016/j.ophtha.2009.05.002 ER - TY - JOUR LB - 3. AU - Kanski, JJ TI - Uveitis in juvenile chronic arthritis: incidence, clinical features and prognosis J2 - Eye PY - 1988 VL - 2 SP - 641 EP - 645 UR - https://doi.org/10.1038/eye.1988.118 ER - TY - JOUR LB - 4. AU - Kotaniemi, K AU - Kautiainen, H AU - Karma, A AU - Aho, K TI - Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study J2 - Ophthalmology PY - 2001 VL - 108 SP - 2071 EP - 2075 UR - https://doi.org/10.1016/S0161-6420(01)00773-4 ER - TY - JOUR LB - 5. AU - Saurenmann, RK AU - Levin, AV AU - Feldman, BM AU - Rose, JB AU - Laxer, RM AU - Schneider, R AU - Silverman, ED TI - Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term follow-up study J2 - Arthritis Rheum PY - 2007 VL - 56 SP - 647 EP - 657 UR - https://doi.org/10.1002/art.22381 ER - TY - JOUR LB - 6. AU - Chia, A AU - Lee, V AU - Graham, EM AU - Edelsten, C TI - Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program J2 - Am J Ophthalmol PY - 2003 VL - 135 SP - 757 EP - 762 UR - https://doi.org/10.1016/S0002-9394(03)00225-3 ER - TY - JOUR LB - 7. AU - Holland, GN AU - Denove, CS AU - Yu, F TI - Chronic anterior uveitis in children: clinical characteristics and complications J2 - Am J Ophthalmol PY - 2009 VL - 147 SP - 667 EP - 78.e5 UR - https://doi.org/10.1016/j.ajo.2008.11.009 ER - TY - JOUR LB - 8. AU - Woreta, F AU - Thorne, JE AU - Jabs, DA AU - Kedhar, SR AU - Dunn, JP TI - Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis J2 - Am J Ophthalmol PY - 2007 VL - 143 SP - 647 EP - 655 UR - https://doi.org/10.1016/j.ajo.2006.11.025 ER - TY - JOUR LB - 9. AU - Edelsten, C AU - Lee, V AU - Bentley, CR AU - Kanski, JJ AU - Graham, EM TI - An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis-associated uveitis and other chronic anterior uveitis in early childhood J2 - Br J Ophthalmol PY - 2002 VL - 86 SP - 51 EP - 56 UR - https://doi.org/10.1136/bjo.86.1.51 ER - TY - JOUR LB - 10. AU - Jabs, DA AU - Nussenblatt, RB AU - Rosenbaum, JT AU - Standardization of Uveitis Nomenclature (SUN) Working Group TI - Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop J2 - Am J Ophthalmol PY - 2005 VL - 140 SP - 509 EP - 516 UR - https://doi.org/10.1016/j.ajo.2005.03.057 ER - TY - JOUR LB - 11. AU - Thorne, JE AU - Woreta, F AU - Kedhar, SR AU - Dunn, JP AU - Jabs, DA TI - Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss J2 - Am J Ophthalmol PY - 2007 VL - 143 SP - 840 EP - 846 UR - https://doi.org/10.1016/j.ajo.2007.01.033 ER - TY - JOUR LB - 12. AU - Wolf, MD AU - Lichter, PR AU - Ragsdale, CG TI - Prognostic factors in the uveitis of juvenile rheumatoid arthritis J2 - Ophthalmology PY - 1987 VL - 94 SP - 1242 EP - 1248 UR - https://doi.org/10.1016/S0161-6420(87)80007-6 ER - TY - JOUR LB - 13. AU - de Boer, J AU - Wulffraat, N AU - Rothova, A TI - Visual loss in uveitis of childhood J2 - Br J Ophthalmol PY - 2003 VL - 87 SP - 879 EP - 884 UR - https://doi.org/10.1136/bjo.87.7.879 ER - TY - JOUR LB - 14. AU - Takken, T AU - Van der Net, J AU - Helders, PJ TI - Methotrexate for treating juvenile idiopathic arthritis J2 - Cochrane Database Syst Rev PY - 2001 VL - 3 SP - CD003129 UR - https://doi.org/10.1002/14651858.CD003129 ER - TY - JOUR LB - 15. AU - Beresford, MW AU - Baildam, EM TI - New advances in the management of juvenile idiopathic arthritis – 1: non-biological therapy J2 - Arch Dis Child Educ Pract Ed PY - 2009 VL - 94 SP - 144 EP - 150 UR - https://doi.org/10.1136/adc.2008.144576 ER - TY - JOUR LB - 16. AU - Foeldvari, I AU - Wierk, A TI - Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis J2 - J Rheumatol PY - 2005 VL - 32 SP - 362 EP - 365 ER - TY - JOUR LB - 17. AU - Weiss, AH AU - Wallace, CA AU - Sherry, DD TI - Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis J2 - J Pediatr PY - 1998 VL - 133 SP - 266 EP - 268 UR - https://doi.org/10.1016/S0022-3476(98)70232-X ER - TY - JOUR LB - 18. AU - Yu, EN AU - Meniconi, ME AU - Tufail, F AU - Baltatzis, S AU - Foster, CS TI - Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis J2 - Ocul Immunol Inflamm PY - 2005 VL - 13 SP - 353 EP - 360 UR - https://doi.org/10.1080/09273940590951061 ER - TY - JOUR LB - 19. AU - Sharma, SM AU - Dick, AD AU - Ramanan, AV TI - Non-infectious pediatric uveitis: an update on immunomodulatory management J2 - Paediatr Drugs PY - 2009 VL - 11 SP - 229 EP - 241 UR - https://doi.org/10.2165/00148581-200911040-00002 ER - TY - JOUR LB - 20. AU - Kalinina Ayuso, V AU - van de Winkel, EL AU - Rothova, A AU - de Boer, JH TI - Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis J2 - Am J Ophthalmol PY - 2011 VL - 151 SP - 217 EP - 222 UR - https://doi.org/10.1016/j.ajo.2010.08.021 ER - TY - JOUR LB - 21. AU - Doycheva, D AU - Deuter, C AU - Stuebiger, N AU - Biester, S AU - Zierhut, M TI - Mycophenolate mofetil in the treatment of uveitis in children J2 - Br J Ophthalmol PY - 2007 VL - 91 SP - 180 EP - 184 UR - https://doi.org/10.1136/bjo.2006.094698 ER - TY - JOUR LB - 22. AU - Kilmartin, DJ AU - Forrester, JV AU - Dick, AD TI - Cyclosporin A therapy in refractory non-infectious childhood uveitis J2 - Br J Ophthalmol PY - 1998 VL - 82 SP - 737 EP - 742 UR - https://doi.org/10.1136/bjo.82.7.737 ER - TY - JOUR LB - 23. AU - Dick, AD AU - Forrester, JV AU - Liversidge, J AU - Cope, AP TI - The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU) J2 - Prog Retin Eye Res PY - 2004 VL - 23 SP - 617 EP - 637 UR - https://doi.org/10.1016/j.preteyeres.2004.06.005 ER - TY - JOUR LB - 24. AU - Imrie, FR AU - Dick, AD TI - Biologics in the treatment of uveitis J2 - Curr Opin Ophthalmol PY - 2007 VL - 18 SP - 481 EP - 486 UR - https://doi.org/10.1097/ICU.0b013e3282f03d42 ER - TY - JOUR LB - 25. AU - Smith, JR AU - Hart, PH AU - Coster, DJ AU - Williams, KA TI - Mice deficient in tumor necrosis factor receptors p55 and p75, interleukin-4, or inducible nitric oxide synthase are susceptible to endotoxin-induced uveitis J2 - Invest Ophthalmol Vis Sci PY - 1998 VL - 39 SP - 658 EP - 661 ER - TY - JOUR LB - 26. AU - Koizumi, K AU - Poulaki, V AU - Doehmen, S AU - Welsandt, G AU - Radetzky, S AU - Lappas, A TI - Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo J2 - Invest Ophthalmol Vis Sci PY - 2003 VL - 44 SP - 2184 EP - 2191 UR - https://doi.org/10.1167/iovs.02-0589 ER - TY - JOUR LB - 27. AU - Diaz-Llopis, M AU - García-Delpech, S AU - Salom, D AU - Udaondo, P AU - Bosch-Morell, F AU - Quijada, A TI - High-dose infliximab prophylaxis in endotoxin-induced uveitis J2 - J Ocul Pharmacol Ther PY - 2007 VL - 23 SP - 343 EP - 350 UR - https://doi.org/10.1089/jop.2006.0148 ER - TY - JOUR LB - 28. AU - Biester, S AU - Deuter, C AU - Michels, H AU - Haefner, R AU - Kuemmerle-Deschner, J AU - Doycheva, D AU - Zierhut, M TI - Adalimumab in the therapy of uveitis in childhood J2 - Br J Ophthalmol PY - 2007 VL - 91 SP - 319 EP - 324 UR - https://doi.org/10.1136/bjo.2006.103721 ER - TY - JOUR LB - 29. AU - Foeldvari, I AU - Nielsen, S AU - Kümmerle-Deschner, J AU - Espada, G AU - Horneff, G AU - Bica, B TI - Tumour necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey J2 - J Rheumatol PY - 2007 VL - 34 SP - 1146 EP - 1150 ER - TY - JOUR LB - 30. AU - Gallagher, M AU - Quinones, K AU - Cervantes-Castañeda, RA AU - Yilmaz, T AU - Foster, CS TI - Biological response modifier therapy for refractory childhood uveitis J2 - Br J Ophthalmol PY - 2007 VL - 91 SP - 1341 EP - 1344 UR - https://doi.org/10.1136/bjo.2007.124081 ER - TY - JOUR LB - 31. AU - Saurenmann, RK AU - Levin, AV AU - Rose, JB AU - Parker, S AU - Rabinovitch, T AU - Tyrrell, PN TI - Tumour necrosis factor-alpha inhibitors in the treatment of childhood uveitis J2 - Rheumatology PY - 2006 VL - 45 SP - 982 EP - 989 UR - https://doi.org/10.1093/rheumatology/kel030 ER - TY - JOUR LB - 32. AU - Sharma, SM AU - Ramanan, AV AU - Riley, P AU - Dick, AD TI - Use of infliximab in juvenile onset rheumatological disease-associated refractory uveitis: efficacy in joint and ocular disease J2 - Ann Rheum Dis PY - 2007 VL - 66 SP - 840 EP - 841 UR - https://doi.org/10.1136/ard.2006.065441 ER - TY - JOUR LB - 33. AU - Tynjälä, P AU - Kotaniemi, K AU - Lindahl, P AU - Latva, K AU - Aalto, K AU - Honkanen, V AU - Lahdenne, P TI - Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis J2 - Rheumatology PY - 2008 VL - 47 SP - 339 EP - 344 UR - https://doi.org/10.1093/rheumatology/kem356 ER - TY - JOUR LB - 34. AU - Schmeling, H AU - Minden, K AU - Foeldvari, I AU - Ganser, G AU - Hospach, T AU - Horneff, G TI - Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry J2 - Arthritis Rheum PY - 2014 VL - 66 SP - 2580 EP - 2589 UR - https://doi.org/10.1002/art.38741 ER - TY - JOUR LB - 35. AU - Smith, JA AU - Thompson, DJ AU - Whitcup, SM AU - Suhler, E AU - Clarke, G AU - Smith, S TI - A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis J2 - Arthritis Rheum PY - 2005 VL - 53 SP - 18 EP - 23 UR - https://doi.org/10.1002/art.20904 ER - TY - JOUR LB - 36. AU - Hale, S AU - Lightman, S TI - Anti-TNF therapies in the management of acute and chronic uveitis J2 - Cytokine PY - 2006 VL - 33 SP - 231 EP - 237 UR - https://doi.org/10.1016/j.cyto.2005.12.012 ER - TY - JOUR LB - 37. AU - Saurenmann, R AU - Levin, A AU - Feldman, B AU - Laxer, R AU - Schneider, R AU - Silverman, E TI - Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNF-alpha agents J2 - J Pediatr PY - 2006 VL - 149 SP - 833 EP - 836 UR - https://doi.org/10.1016/j.jpeds.2006.08.044 ER - TY - JOUR LB - 38. AU - Taban, M AU - Dupps, WJ AU - Mandell, B AU - Perez, VL TI - Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature J2 - Ocul Immunol Inflamm PY - 2006 VL - 14 SP - 145 EP - 150 UR - https://doi.org/10.1080/09273940600659393 ER - TY - JOUR LB - 39. AU - Lim, LL AU - Fraunfelder, FW AU - Rosenbaum, JT TI - Do tumor necrosis factor inhibitors cause uveitis? A registry-based study J2 - Arthritis Rheum PY - 2007 VL - 56 SP - 3248 EP - 3252 UR - https://doi.org/10.1002/art.22918 ER - TY - JOUR LB - 40. AU - Keystone, EC AU - Kavanaugh, AF AU - Sharp, JT AU - Tannenbaum, H AU - Hua, Y AU - Teoh, LS TI - Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal anti-body) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial J2 - Arthritis Rheum PY - 2004 VL - 50 SP - 1400 EP - 1411 UR - https://doi.org/10.1002/art.20217 ER - TY - JOUR LB - 41. AU - Lovell, DJ AU - Ruperto, N AU - Goodman, S AU - Reiff, A AU - Jung, L AU - Jarosova, K TI - Adalimumab with or without methotrexate in juvenile rheumatoid arthritis J2 - N Engl J Med PY - 2008 VL - 359 SP - 810 EP - 820 UR - https://doi.org/10.1056/NEJMoa0706290 ER - TY - JOUR LB - 42. AU - Vazquez-Cobian, LB AU - Flynn, T AU - Lehman, TJ TI - Adalimumab therapy for childhood uveitis J2 - J Pediatr PY - 2006 VL - 149 SP - 572 EP - 575 UR - https://doi.org/10.1016/j.jpeds.2006.04.058 ER - TY - JOUR LB - 43. AU - Shepherd, J AU - Cooper, K AU - Harris, P AU - Picot, J AU - Rose, M TI - The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation J2 - Health Technol Assess PY - 2016 VL - 20 IS - 34 UR - https://doi.org/10.3310/hta20340 ER - TY - JOUR LB - 44. AU - Cummins, C AU - Connock, M AU - Fry-Smith, A AU - Burls, A TI - A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept J2 - Health Technol Assess PY - 2002 VL - 6 IS - 17 UR - https://doi.org/10.3310/hta6170 ER - TY - JOUR LB - 45. AU - Ungar, WJ AU - Costa, V AU - Hancock-Howard, R AU - Feldman, BM AU - Laxer, RM TI - Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs J2 - Arthritis Care Res PY - 2011 VL - 63 SP - 111 EP - 119 UR - https://doi.org/10.1002/acr.20337 ER - TY - JOUR LB - 46. AU - Simpson, K AU - Marlow, N AU - Shaw, J AU - Rudakova, A TI - Pharmacoeconomic issues of adalimumab therapy in juvenile idiopathic arthritis J2 - Pediatr Pharmacol PY - 2012 VL - 9 SP - 48 EP - 52 UR - https://doi.org/10.15690/pf.v9i4.390 ER - TY - JOUR LB - 47. AU - Prince, FH AU - de Bekker-Grob, EW AU - Twilt, M AU - van Rossum, MA AU - Hoppenreijs, EP AU - ten Cate, R TI - An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register J2 - Rheumatology PY - 2011 VL - 50 SP - 1131 EP - 1136 UR - https://doi.org/10.1093/rheumatology/keq432 ER - TY - JOUR LB - 48. AU - Squires, H AU - Poku, E AU - Bermejo, I AU - Cooper, K AU - Stevens, J AU - Hamilton, J TI - A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults J2 - Health Technol Assess PY - 2017 VL - 21 IS - 68 UR - https://doi.org/10.3310/hta21680 ER - TY - JOUR LB - 49. AU - Ramanan, AV AU - Dick, AD AU - Benton, D AU - Compeyrot-Lacassagne, S AU - Dawoud, D AU - Hardwick, B TI - A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial) J2 - Trials PY - 2014 VL - 15 SP - 14 UR - https://doi.org/10.1186/1745-6215-15-14 ER - TY - ELEC LB - 50. AU - Medicines and Healthcare products Regulatory Agency TI - Good Clinical Practice for Clinical Trials. PY - 2014 UR - www.gov.uk/guidance/good-clinical-practice-for-clinical-trials M1 - 4 February 2019 ER - TY - BOOK LB - 51. AU - Great Britain TI - The Medicines for Human Use (Clinical Trials) Regulations 2004 CY - London PB - The Stationery Office PY - 2004 ER - TY - JOUR LB - 52. AU - Oliveira, S AU - Ravelli, A AU - Pistorio, A AU - Castell, E AU - Malattia, C AU - Prieur, AM TI - Proxy-reported healthrelated quality of life of patients with juvenile idiopathic arthritis: the paediatric rheumatology international trials organisation multinational quality of life cohort study J2 - Arthritis Care Res PY - 2007 VL - 1 SP - 35 EP - 43 UR - https://doi.org/10.1002/art.22473 ER - TY - JOUR LB - 53. AU - Nugent, J AU - Ruperto, N AU - Grainger, J AU - Machado, C AU - Sawhney, S AU - Baildam, E TI - The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) J2 - Clin Exp Rheumatol PY - 2001 VL - 19 IS - Suppl. 23 SP - S163 EP - S167 ER - TY - JOUR LB - 54. AU - Giannini, EH AU - Ruperto, N AU - Ravelli, A AU - Lovell, DJ AU - Felson, DT AU - Martini, A TI - Preliminary definition of improvement in juvenile arthritis J2 - Arthritis Rheum PY - 1997 VL - 40 SP - 1202 EP - 1209 UR - https://doi.org/10.1002/1529-0131(199707)40:7.lt;1202::AID-ART3.gt;3.0.CO;2-R ER - TY - JOUR LB - 55. AU - Brunner, HI AU - Lovell, DJ AU - Finck, BK AU - Giannini, EH TI - Preliminary definition of disease flare in juvenile rheumatoid arthritis J2 - J Rheumatol PY - 2002 VL - 29 SP - 1058 EP - 1064 ER - TY - JOUR LB - 56. AU - Wallace, CA AU - Ruperto, N AU - Giannini, E AU - Childhood Arthritis and Rheumatology Research Alliance TI - Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis J2 - J Rheumatol PY - 2004 VL - 31 SP - 2290 EP - 2294 ER - TY - JOUR LB - 57. AU - Magni-Manzoni, S AU - Ruperto, N AU - Pistorio, A AU - Sala, E AU - Solari, N AU - Palmisani, E TI - Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis J2 - Arthritis Rheum PY - 2008 VL - 59 SP - 1120 EP - 1127 UR - https://doi.org/10.1002/art.23916 ER - TY - JOUR LB - 58. AU - Consolaro, A AU - Ruperto, N AU - Bazso, A AU - Pistorio, A AU - Magni-Manzoni, S AU - Filocamo, G TI - Development and validation of a composite disease activity score for juvenile idiopathic arthritis J2 - Arthritis Rheum PY - 2009 VL - 61 SP - 658 EP - 666 UR - https://doi.org/10.1002/art.24516 ER - TY - JOUR LB - 59. AU - Ilowite, NT TI - Update on biologics in juvenile idiopathic arthritis J2 - Curr Opin Rheumatol PY - 2008 VL - 20 SP - 613 EP - 618 UR - https://doi.org/10.1097/BOR.0b013e3283060778 ER - TY - JOUR LB - 60. AU - Ruperto, N AU - Lovell, DJ AU - Cuttica, R AU - Wilkinson, N AU - Woo, P AU - Espada, G TI - A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis J2 - Arthritis Rheum PY - 2007 VL - 56 SP - 3096 EP - 3106 UR - https://doi.org/10.1002/art.22838 ER - TY - ELEC LB - 61. AU - Arthritis UK TI - Research Policy – Observational Data and Sample Collection UR - www.versusarthritis.org/media/1384/observational-data-and-sample-collection-policy.pdf M1 - 4 February 2019 ER - TY - JOUR LB - 62. AU - Pocock, SJ TI - Current controversies in data monitoring for clinical trials J2 - Clin Trials PY - 2006 VL - 3 SP - 513 EP - 521 UR - https://doi.org/10.1177/1740774506073467 ER - TY - JOUR LB - 63. AU - Ramanan, AV AU - Dick, AD AU - Jones, AP AU - McKay, A AU - Williamson, PR AU - Compeyrot-Lacassagne, S AU - Hardwick, B AU - for the SYCAMORE Study Group TI - Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis J2 - N Engl J Med PY - 2017 VL - 376 SP - 1637 EP - 1646 UR - https://doi.org/10.1056/NEJMoa1614160 ER - TY - JOUR LB - 64. AU - Schulz, KF AU - Altman, DG AU - Moher, D AU - CONSORT Group TI - CONSORT 2010 Statement: updated guidelines for reporting parallel-group randomised trials J2 - BMC Med PY - 2010 VL - 8 SP - 18 UR - https://doi.org/10.1186/1741-7015-8-18 ER - TY - JOUR LB - 65. AU - Henderson, R AU - Diggle, P AU - Dobson, A TI - Joint modelling of longitudinal measurements and event time data J2 - Biostatistics PY - 2000 VL - 1 SP - 465 EP - 480 UR - https://doi.org/10.1093/biostatistics/1.4.465 ER - TY - BOOK LB - 66. AU - NHS Business Services Authority (NHS BSA) TI - Prescription Cost Analysis Data CY - Newcastle upon Tyne PB - NHS BSA UR - www.nhsbsa.nhs.uk/prescription-data/dispensing-data/prescription-cost-analysis-pca-data M1 - 6 March 2019 ER - TY - BOOK LB - 67. AU - Joint Formulary Committee TI - British National Formulary CY - London PB - BMJ Group and Pharmaceutical Press PY - 2017 ER - TY - BOOK LB - 68. AU - NHS England TI - NHS National Tariff Payment System 2016/17 CY - Leeds PB - NHS England PY - 2016 UR - www.gov.uk/government/publications/nhs-national-tariff-payment-system-201617 M1 - 31 October 2016 ER - TY - BOOK LB - 69. AU - NHS England TI - A Simple Guide to Payment by Results CY - Leeds PB - NHS England PY - 2013 UR - www.gov.uk/government/uploads/system/uploads/attachment_data/file/213150/PbR-Simple-Guide-FINAL.pdf M1 - 9 November 2018 ER - TY - BOOK LB - 70. AU - NHS England TI - NHS Reference Costs 2015 to 2016 CY - Leeds PB - NHS England PY - 2016 UR - www.gov.uk/government/publications/nhs-reference-costs-2015-to-2016 M1 - 3 October 2017 ER - TY - BOOK LB - 71. AU - Curtis, L AU - Burns, A TI - Unit Costs of Health and Social Care 2015 CY - Canterbury PB - Personal Social Services Research Unit, University of Kent PY - 2015 ER - TY - JOUR LB - 72. AU - Geue, C AU - Lewsey, J AU - Lorgelly, P AU - Govan, L AU - Hart, C AU - Briggs, A TI - Spoilt for choice: implications of using alternative methods of costing hospital episode statistics J2 - Health Econ PY - 2012 VL - 21 SP - 1201 EP - 1216 UR - https://doi.org/10.1002/hec.1785 ER - TY - BOOK LB - 73. AU - Furlong, W AU - Feeny, D AU - Torrance, G AU - Goldsmith, C AU - DePauw, S AU - Zhu, Z TI - Multiplicative Multi-Attribute Utility Function for the HUI Mark 3 (HUI3) System: a Technical Report CHEPA Working Paper T2 - Centre for Health Economics and Policy Analysis Working Paper Series 1998–11 CY - Hamilton, ON PB - Centre for Health Economics and Policy Analysis (CHEPA) PY - 1998 ER - TY - JOUR LB - 74. AU - Cann, M AU - Ramanan, AV AU - Crawford, A AU - Dick, AD AU - Clarke, SLN AU - Rashed, F AU - Guly, CM TI - Outcomes of non-infectious paediatric uveitis in the era of biologic therapy J2 - Pediatr Rheumatol Online J PY - 2018 VL - 16 SP - 51 UR - https://doi.org/10.1186/s12969-018-0266-5 ER - TY - ELEC LB - 75. AU - Shkolnikov, V AU - Barbieri, MWJ TI - The Human Mortality Database PY - 2017 UR - www.mortality.org M1 - 3 October 2017 ER - TY - JOUR LB - 76. AU - Davies, R AU - Southwood, T AU - Kearsley-Fleet, L AU - Lunt, M AU - Hyrich, KL TI - FRI0557 standardized mortality rates are increased in patients with severe juvenile idiopathic arthritis J2 - Ann Rheum Dis PY - 2014 VL - 73 SP - 588 UR - https://doi.org/10.1093/rheumatology/keu496 ER - TY - JOUR LB - 77. AU - White, IR AU - Royston, P AU - Wood, AM TI - Multiple imputation using chained equations: issues and guidance for practice J2 - Stat Med PY - 2011 VL - 30 SP - 377 EP - 399 UR - https://doi.org/10.1002/sim.4067 ER - TY - JOUR LB - 78. AU - Sussman, JB AU - Hayward, RA TI - An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials J2 - BMJ PY - 2010 VL - 340 SP - c2073 UR - https://doi.org/10.1136/bmj.c2073 ER - TY - JOUR LB - 79. AU - Fenwick, E AU - Claxton, K AU - Sculpher, M TI - Representing uncertainty: the role of cost-effectiveness acceptability curves J2 - Health Econ PY - 2001 VL - 10 SP - 779 EP - 787 UR - https://doi.org/10.1002/hec.635 ER - TY - BOOK LB - 80. AU - National Institute for Health and Care Excellence (NICE) TI - Guide to the Methods Of Technology Appraisal 2013. Process and Methods [PMG9] CY - London PB - NICE PY - 2013 UR - www.nice.org.uk/process/pmg9/ M1 - 10 January 2019 ER - TY - JOUR LB - 81. AU - Husereau, D AU - Drummond, M AU - Petrou, S AU - Carswell, C AU - Moher, D AU - Greenberg, D TI - Consolidated Health Economic Evaluation Reporting Standards (CHEERS) – explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force J2 - Value Health PY - 2013 VL - 16 SP - 231 EP - 250 UR - https://doi.org/10.1016/j.jval.2013.02.002 ER - TY - JOUR LB - 82. AU - Sen, ES AU - Dick, AD AU - Ramanan, AV TI - Uveitis associated with juvenile idiopathic arthritis J2 - Nat Rev Rheumatol PY - 2015 VL - 11 SP - 338 EP - 348 ER -